Phase 2 Head and Neck Cancer Trial, Recruiting NCT06301165 Sponsor: Sun Yat-sen University Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Phase 2 Head and Neck Cancer Trial, Recruiting

NCT06301165
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old
  • Your cancer has been confirmed by a tissue sample as a specific type of nasopharyngeal carcinoma (a cancer in the back of the nose/throat), classified as WHO type II or III
  • Your cancer has been staged at a locally advanced level with no spread to distant parts of the body (confirm with trial site for exact staging details)
  • You are generally able to carry out daily activities with little or no limitation (rated 0 or 1 on a standard activity scale)
  • Your blood cell counts are at acceptable levels, meaning your white blood cells, red blood cells, and platelets are all within required ranges
  • Your liver is functioning well enough, based on standard blood tests
  • Your kidneys are functioning well enough, based on standard blood or urine tests
  • If you are a woman who could become pregnant, or a sexually active man, you must agree to use effective contraception throughout the treatment period
  • You understand the nature of the study and are willing to sign a consent form

Who may not be able to join:

  • Your cancer is a different type, specifically keratinizing squamous cell carcinoma or basaloid squamous cell carcinoma
  • Your treatment is intended only to manage symptoms rather than to treat the cancer directly (palliative treatment)
  • You have had a previous cancer, unless it was an early-stage cervical cancer or a common type of skin cancer that was fully treated
  • You have had radiotherapy in the past, unless it was for a minor skin cancer in a completely different area of the body
  • You have previously had chemotherapy or surgery (other than for diagnosis) for this cancer
  • You are currently pregnant or breastfeeding
  • You have another serious illness that could make the trial unsafe or make it hard for you to follow the treatment plan, such as unstable heart disease, serious kidney or liver disease, poorly controlled diabetes, or significant emotional or mental health difficulties
  • You have previously had an allergic reaction to any of the drugs being used in this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 086-020-8734

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
19 March 2024
Est. completion
31 December 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Progression-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov